Clinical Trial Update: A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection. [Phase 2]

View source ↗

Summary

Pfizer's Phase 2 trial of sisunatovir in infants with respiratory syncytial virus lower respiratory tract infection has been terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Respiratory Tract Infection
• Respiratory Syncytial Virus Infection

Drugs mentioned

• Sisunatovir (Sisunatovir)

Snippet

Sponsor: Pfizer | Conditions: Respiratory Syncytial Virus (RSV), Lower Resp Tract Infection | Phase 2 | Status: TERMINATED | Results posted: 2024-10-23